ICD-10-CM code · FY2027
F15.90 Other stimulant use, unspecified, uncomplicated
BillableValid for claims as a specific diagnosis code
About F15.90
- Code
- F15.90
- Billable
- Yes
- Short description
- Other stimulant use, unspecified, uncomplicated
- Category
- F15 Other stimulant related disorders
- Block
- F10-F19 Mental and behavioral disorders due to psychoactive substance use
- Chapter
- 5 Mental, Behavioral and Neurodevelopmental disorders
- Code set
- FY2027, October 1, 2026 to September 30, 2027
EvidencePulse™by 2 Minute Medicine®
Go deeper into stimulant use.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for F15.90
No notes of its own; the notes below apply from the codes above it.
Also applies, from F15.9 Other stimulant use, unspecified
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Also applies, from F15 Other stimulant related disorders
Includes Conditions this code covers.
- amphetamine-related disorders
- caffeine
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- cocaine-related disorders (F14.-)
Chapter 5 notes (apply to every code in it)
Includes Conditions this code covers.
- disorders of psychological development
Related codes in F15.9
- F15.91 Other stimulant use, unspecified, in remissionBillable
- F15.92 Other stimulant use, unspecified with intoxicationHeader
- F15.93 Other stimulant use, unspecified with withdrawalBillable
- F15.94 Other stimulant use, unspecified with stimulant-induced mood disorderBillable
- F15.95 Other stimulant use, unspecified with stimulant-induced psychotic disorderHeader
- F15.98 Other stimulant use, unspecified with other stimulant-induced disorderHeader
- F15.99 Other stimulant use, unspecified with unspecified stimulant-induced disorderBillable
Latest research on stimulant use
- Co-use of methamphetamine and opioids associated with higher rates of nonfatal overdoses compared to independent use
- Exercise and dance may reduce cravings associated with methamphetamine abuse in women
- Naltrexone-bupropion treatment provides a higher response for methamphetamine use disorder
- Looksmaxxing raises body dysmorphia concerns among adolescent males
- The Scan by 2 Minute Medicine®: Viral menopause cocktail lacks evidence, maxxing trends raise dysmorphia concerns, Ebola cases surpass 5,000, and coffee consumption is linked to lower visceral fat
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app